|
| |
DiarrheaDownload PDF containing detailed information.
Recent Publications on Diarrhea: |  |
CLINICAL AND LABORATORY FEATURES OF RADIOLOGIC PNEUMONIA IN SEVERELY MALNOURISHED INFANTS ATTENDING AN URBAN DIARRHEA TREATMENT CENTER IN BANGLADESH.
We described clinical and laboratory features of infants having radiologic... | 21st November, 2009
| From the Clinical Sciences Division, International Centre for Diarrhoeal
| Pediatr Infect Dis J. 2009 Nov 18.
DOI Direct Link |
Enteric nervous system: sensory physiology, diarrhea and constipation.
PURPOSE OF REVIEW: The enteric nervous system integrates secretion and... | 21st November, 2009
| Department of Physiology and Cell Biology and Department of Internal
| Curr Opin Gastroenterol. 2009 Nov 18.
DOI Direct Link |
Molecular detection of novel adenoviruses in fecal specimens of captive monkeys with diarrhea in China.
Adenovirus (AdV) has been recently detected among monkeys with diarrhea in... | 21st November, 2009
| Division of Viral Diseases, Centers for Disease Control and Prevention,
| Vet Microbiol. 2009 Oct 28.
DOI Direct Link |
NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice.
Peptide YY (PYY)(3-36), a neuropeptide Y (NPY) Y2 receptor agonist, is a... | 21st November, 2009
| Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Okubo 3,
| Peptides. 2009 Nov 16.
DOI Direct Link |
Body fluids and salt metabolism - Part I.
ABSTRACT: There is a high frequency of diarrhea and vomiting in childhood.... | 21st November, 2009
|
| Ital J Pediatr. 2009 Nov 19;35(1):36.
DOI Direct Link |
→View more research publications. |
Press Releases About Diarrhea:
|
 |
| Reportlinker Adds Probiotics - A Global Update of Market Trends & Opportunities |
25th November, 2009 |
Reportlinker |
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Probiotics - A Global Update of Market Trends & Opportunities
http:/
|
| Optimer Pharmaceuticals Announces Presentations of Additional Data From the Fidaxomicin North American Phase 3 Trial at Upcoming IDSA Annual Meeting |
19th October, 2009 |
Optimer Pharmaceuticals, Inc. |
SAN DIEGO, Oct. 19 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced that additional data related to fidaxomicin, the Company's lead developmental product candidate
|
| Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial |
9th July, 2009 |
Rigel Pharmaceuticals, Inc. |
SOUTH SAN FRANCISCO, Calif., July 9 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that R788 (fostamatinib disodium) produced significant clinical improvement in
|
| Intercell to Webcast Research & Development Day on Thursday, June 4, 2009 |
27th May, 2009 |
Intercell AG |
VIENNA and GAITHERSBURG, Md., May 27 /PRNewswire/ -- Intercell AG (VSE: ICLL) today announced that it will webcast its Research & Development Day being held in New York on Thursday, June 4
|
| Intercell Executes Multi-Year Contract for Supply of IXIARO(R) to the United States Military |
8th May, 2009 |
Intercell AG |
- Exclusive, multi-year contract executed by Intercell and U.S. Department of Defense for purchase of IXIARO(R)
- First sales of IXIARO under this military contract expected soon
VIENNA, May 8
|
Diarrhea Patents: |  |
| US Patent No. | Title |
| 7608600 | Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 7611857 | IL-receptor like molecules and uses thereof |
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor |
| 7612035 | Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma |
| 7612045 | Compounds, compositions and methods for controlling biofilms and bacterial infections |
→View more patents. |
Companies working in the area of Diarrhea from Bioportfolio's Biocorporate database : | |
| Company Name | |
Cera Products, Inc. was established in 1993 in Maryland and works with worldwide public health and medical experts to develop products that will help promote early recovery from diarrhea and prevent...
www.ceraproductsinc.com/ View full profile
| |
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique...
www.iomai.com/ View full profile
| |
Active Pass is developing treatments for the symptoms of infectious disease. Our first product targets severe secretory diarrhea. Diarrhea is often viewed as a 3rd world problem, but in North America...
www.activepass.com/ View full profile
| | →View more Diarrhea related companies. |
BioPortfolio Ltd. offers e-mail and postal lists for Diarrhea scientists - we have details of around 5818 individuals working on Diarrhea .
This page has been viewed 536 times
Recent Search Terms used to find this page: global impact of diarrhea 2009 | intercell clostridium difficile | 2009 diarrhea | montreal february 2009 diarrhea | diarrhea recovery | why do diabetics get diarrhea | barigye r, | barigye r, | diarrhea dec 08 | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Diarrhea across BioPortfolio, or for Diarrhea Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
